These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23192599)

  • 21. Intensifying treatment of type 2 diabetes mellitus: adding insulin.
    Peters KR
    Pharmacotherapy; 2011 Dec; 31(12 Suppl):54S-64S. PubMed ID: 22122223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical decision support systems in the care of inpatients with diabetes in non-critical care setting: systematic review.
    Nirantharakumar K; Chen YF; Marshall T; Webber J; Coleman JJ
    Diabet Med; 2012 Jun; 29(6):698-708. PubMed ID: 22150466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin adherence in patients with diabetes: risk factors for injection omission.
    Farsaei S; Radfar M; Heydari Z; Abbasi F; Qorbani M
    Prim Care Diabetes; 2014 Dec; 8(4):338-45. PubMed ID: 24721139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fine-tuning therapy with basal insulin for optimal glycemic control in type 2 diabetes: a review.
    Dailey G
    Curr Med Res Opin; 2004 Dec; 20(12):2007-14. PubMed ID: 15701217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of insulin therapy algorithms on blood glucose levels in patients following cardiac surgery: A systematic review.
    Higgs M; Fernandez R
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):205-43. PubMed ID: 26455610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimed and reduced doses.
    Brod M; Rana A; Barnett AH
    Curr Med Res Opin; 2012 Dec; 28(12):1933-46. PubMed ID: 23150949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic literature review of methodologies used to assess medication adherence in patients with diabetes.
    Clifford S; Perez-Nieves M; Skalicky AM; Reaney M; Coyne KS
    Curr Med Res Opin; 2014 Jun; 30(6):1071-85. PubMed ID: 24432796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient and physician factors associated with adherence to diabetes medications.
    Schoenthaler AM; Schwartz BS; Wood C; Stewart WF
    Diabetes Educ; 2012; 38(3):397-408. PubMed ID: 22446035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes.
    Eby EL; Van Brunt K; Brusko C; Curtis B; Lage MJ
    Clin Interv Aging; 2015; 10():991-1001. PubMed ID: 26124652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
    Machoy M
    Ann Acad Med Stetin; 2004; 50(2):29-39. PubMed ID: 16529163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of adherence to diabetes treatment.
    Larkin AT; Hoffman C; Stevens A; Douglas A; Bloomgarden Z
    J Diabetes; 2015 Nov; 7(6):864-71. PubMed ID: 25565088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin therapy in type 2 diabetes: what is the evidence?
    van Avendonk MJ; Rutten GE
    Diabetes Obes Metab; 2009 May; 11(5):415-32. PubMed ID: 19175375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges associated with insulin therapy in type 2 diabetes mellitus.
    Edelman S; Pettus J
    Am J Med; 2014 Oct; 127(10 Suppl):S11-6. PubMed ID: 25282008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Greater fear of hypoglycaemia with premixed insulin than with basal-bolus insulin glargine and glulisine: patient-reported outcomes from a 60-week randomised study.
    Polonsky WH; Thompson S; Wei W; Riddle MC; Chaudhari S; Jackson J; Bruno AS
    Diabetes Obes Metab; 2014 Nov; 16(11):1121-7. PubMed ID: 24919603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities.
    Brod M; Alolga SL; Meneghini L
    Patient; 2014; 7(4):437-50. PubMed ID: 24958464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physician experiences when discussing the need for additional oral medication with type 2 diabetes patients: Insights from the cross-national IntroDia® study.
    Down S; Alzaid A; Polonsky WH; Belton A; Edelman S; Gamerman V; Nagel F; Lee J; Emmerson J; Capehorn M
    Diabetes Res Clin Pract; 2019 Feb; 148():179-188. PubMed ID: 30641173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals.
    Leiter LA; Boras D; Woo VC
    Can J Diabetes; 2014 Feb; 38(1):38-44. PubMed ID: 24485212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescriber Compliance with a New Computerized Insulin Guideline for Noncritically Ill Adults.
    Clemens E; Cutler T; Canaria J; Pandya K; Parker P
    Ann Pharmacother; 2011 Feb; 45(2):154-61. PubMed ID: 21245289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers and facilitators to starting insulin in patients with type 2 diabetes: a systematic review.
    Ng CJ; Lai PS; Lee YK; Azmi SA; Teo CH
    Int J Clin Pract; 2015 Oct; 69(10):1050-70. PubMed ID: 26147376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.